Drugs / A2NTX
A2NTX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01910363 | Jul 2013 → Jan 2014 | — | University of Tokushima | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A2NTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01910363 ↗ |
| Known as | A2NTX:low molecular weight (150kDalton) purified botulinum toxin type A2 preparation | “A2NTX:low molecular weight (150kDalton) purified botulinum toxin type A2 preparation” NCT01910363 ↗ |
| Modality | Protein / enzyme biologic | “botulinum toxin preparation” NCT01910363 ↗ |
| Route | Intramuscular | “Intramuscular injection of the botulinum toxin preparation” NCT01910363 ↗ |